1. Home
  2. CENX vs FOLD Comparison

CENX vs FOLD Comparison

Compare CENX & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Aluminum Company

CENX

Century Aluminum Company

HOLD

Current Price

$30.78

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$9.92

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENX
FOLD
Founded
1995
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Aluminum
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
CENX
FOLD
Price
$30.78
$9.92
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$33.00
$30.29
AVG Volume (30 Days)
2.6M
4.6M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.83
N/A
Revenue
$2,525,100,000.00
$598,704,000.00
Revenue This Year
$16.07
$21.12
Revenue Next Year
N/A
$21.23
P/E Ratio
$37.06
N/A
Revenue Growth
20.15
21.28
52 Week Low
$13.05
$5.51
52 Week High
$34.52
$10.57

Technical Indicators

Market Signals
Indicator
CENX
FOLD
Relative Strength Index (RSI) 56.86 64.67
Support Level $25.40 $9.56
Resistance Level $30.19 $10.05
Average True Range (ATR) 1.30 0.37
MACD 0.32 -0.02
Stochastic Oscillator 90.20 51.14

Price Performance

Historical Comparison
CENX
FOLD

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: